What is the typical administration route for volume expanders in neonatal care?

In neonatal care, the typical administration route for volume expanders is via intravenous (IV) or intraosseous (IO) access. This method is crucial for rapid fluid administration in situations such as dehydration or shock, where immediate and effective restoration of intravascular volume is necessary to maintain perfusion and cardiac output.

Using IV access allows healthcare providers to deliver volume expanders directly into the bloodstream, ensuring quick distribution throughout the body. In cases where IV access is challenging or delayed, intraosseous access provides a viable alternative; it involves injecting fluids directly into the bone marrow, which rapidly absorbs fluids into the systemic circulation, mirroring the effects of IV administration.

Other routes, such as oral, intramuscular, or subcutaneous, are not suitable for administering volume expanders in emergencies. Oral administration is impractical for neonates who may be unstable, while intramuscular injections provide slower absorption and are not effective for immediate volume resuscitation. Subcutaneous administration also lacks the rapid absorption needed in critical situations. Thus, IV and intraosseous routes are the preferred methods for ensuring a swift and effective response to the needs of neonates in distress.